# Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)

> **NCT01133626** · PHASE3 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 107 (actual)

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Placebo Nasal Aerosol
- **DRUG:** Prednisone capsules
- **DRUG:** Placebo Prednisone Capsules
- **DRUG:** Beclomethasone dipropionate

## Key facts

- **NCT ID:** NCT01133626
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2012-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01133626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01133626, "Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01133626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*